Clinical implications of ovarian reserve testing

Obstetrical and Gynecological Survey

Volumn 64, Issue 2, 2009, Pages 120-128

  Steiner, Anne Z ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR; INHIBIN;

AGE DISTRIBUTION; AGING; BIOASSAY; FEMALE INFERTILITY; FERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUATION; OOCYTE; OUTCOME ASSESSMENT; OVARIAN FUNCTION TEST; OVARY FUNCTION; OVARY RESERVE; POPULATION RESEARCH; PREGNANCY; REVIEW; RISK FACTOR; SMOKING; TREATMENT FAILURE; BLOOD; FEMALE; OVARY; PHYSIOLOGY; URINE;

ANTI-MULLERIAN HORMONE; FEMALE; HUMANS; INHIBINS; MENOPAUSE; OVARY;

EID: 65549111235     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181932e3f     Document Type: Review

References (115)

1. US Bureau of the Census. Percent of people 25 years and over who have completed high school or college, by race, hispanic origin, and sex: selected years 1940 to 2004 (Noninstitutionalized population). Available at: http://www. census.gov/population/socdemo/education/tabA-2.pdf. Accessed December 29, 2006.
2. Stephen EH, Chandra A. Declining estimates of infertility in the United States: 1982-2002. Fertil Steril 2006;86:516-523.
3. Mathews TJ, Hamilton BE. Mean age of mother, 1970-2000. Natl Vital Stat Rep 2002;51:1-13.
4. Ventura SJ, Hamilton BE, Sutton PD. Revised birth and fertility rates for the United States, 2000 and 2001. Natl Vital Stat Rep 2003;51:1-18.
5. Martin JA, Hamilton BE, Ventura SJ, et al. Births: final data from 2000. Natl Vital Stat Rep 2002;50:1-101.
6. Abma JC, Chandra A, Mosher WD, et al. Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth. Vital Health Stat 1997;23:1-114.
7. Gnoth C, Godehardt D, Godehardt E, et al. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod 2003;18:1959-1966.
8. Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med 1982;306:404-406.
9. 9. Soules MR, Sherman S, Parrott E, et al. Executive summary: stages of reproductive aging workshop (STRAW). Fertil Steril 2001;76:874-878. (Pubitemid 33031310)
10. O'Connor KA, Holman DJ, Wood JW. Declining fecundity and ovarian ageing in natural fertility populations. Maturitas 1998;30:127-136.
11. Steiner AZ, Paulson RJ. Oocyte donation. Clin Obstet Gynecol 2006;49:44-54.
12. Gougeon A, Chainy GB. Morphometric studies of small follicles in ovaries of women at different ages. J Reprod Fertil 1987;81:433-442.
13. Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992;7:1342-1346.
14. Khalifa E, Toner JP, Muasher SJ, et al. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization. Fertil Steril 1992;57:835-839.
15. Brook JD, Gosden RG, Chandley AC. Maternal ageing and aneuploid embryos-evidence from the mouse that biological and not chronological age is the important influence. Hum Genet 1984;66:41-45.
16. HardyR,KuhD. ReproductivecharacteristicsandtheageatinceptionoftheperimenopauseinaBritish NationalCohort.AmJEpidemiol1999;149:612-620.(Pubitemid29162710)
17. Henderson SA, Edwards RG. Chiasma frequency and maternal age in mammals. Nature 1968;218:22-28.
18. 18. Volarcik K, Sheean L, Goldfarb J, et al. The meiotic competence of in-vitro matured human oocytes is influenced by donor age: evidence that folliculogenesis is compromised in the reprod ucti vely aged ovary. Hum Reprod 1998;13:154-160. (Pubitemid 28075293)
19. Angell R. First-meiotic-division nondisjunction in human oocytes. Am J Hum Genet 1997;61:23-32.
20. Pellicer A, Mari M, los Santos MJ, et al. Effects of aging on the human ovary: the secretion of immunoreactive alphainhibin and progesterone. Fertil Steril 1994;61:663-668.
21. Seifer DB, Gardiner AC, Lambert-Messerlian G, et al. Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. J Clin Endocrinol Metab 1996;81:736-739.
22. Klein NA, Battaglia DE, Miller PB, et al. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. J Clin Endocrinol Metab 1996;81:1946-1951.
23. Seifer DB, Charland C, Berlinsky D, et al. Proliferative index of human luteinized granulosa cells varies as a function of ovarian reserve. Am J Obstet Gynecol 1993;169:1531-1535.
24. Seifer DB, Gardiner AC, Ferreira KA, et al. Apoptosis as a function of ovarian reserve in women undergoing in vitro fertilization. Fertil Steril 1996;66:593-598.
25. Scheffer GJ, Broekmans FJ, Dorland M, et al. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999;72:845-851.
26. 26. Burger HG, Cahir N, Robertson DM, et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) 1998;48:809-813. (Pubitemid 28289252)
27. LeeSJ,LentonEA,SextonL,etal. TheeffectofageonthecyclicalpatternsofplasmaLH,FSH, oestradiolandprogesteroneinwomenwithregularmenstrualcycles.HumReprod1988;3: 851-855.(Pubitemid18239519)
28. Hansen KR, Thyer AC, Sluss PM, et al. Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women? Hum Reprod 2005;20:89-95.
29. Lee MM, Donahoe PK. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993;14: 152-164.
30. 30. Roberts VJ, Barth S, el Roeiy A, et al. Expression of inhibin/ activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 1993; 77:1402-1410. (Pubitemid 23345505)
31. Klein NA, lllingworth PJ, Groome NP, et al. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 1996;81:2742-2745.
32. Santoro N, Isaac B, Neal-Perry G, et al. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab 2003;88:5502-5509.
33. CheckJH,LissJR,ShucoskiK,etal. Effectofshortfollicularphasewithfollicularmaturityonconceptionoutcome. ClinExpObstetGynecol2003;30:195-196.(Pubitemid37456313)
34. FukudaM,FukudaK,AndersenCY,etal. Characteristicsofhumanovulationinnaturalcyclescorrelatedwithageandachievemen tofpregnancy.HumReprod2001;16:2501-2507.(Pubitemid34007463)
35. Backer LC, Rubin CS, Marcus M, et al. Serum folliclestimulating hormone and luteinizing hormone levels in women aged 35 to 60 in the US population: the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). Menopause 1999;6:29-35.
36. Kim YK, Wasser SK, Fujimoto VY, et al. Utility of follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol, and FSH: LH ratio in predicting reproductive age in normal women. Hum Reprod 1997;12:1152-1155.
37. Ng EH, Yeung WS, Fong DY, et al. Effects of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility. Hum Reprod 2003;18:21692174.
38. Tufan E, Elter K, Durmusoglu F. Assessment of reproductive ageing patterns by hormonal and ultrasonographic ovarian reserve tests. Hum Reprod 2004;19:2484-2489.
39. Broekmans FJ, Scheffer GJ, Bancsi LF, et al. Ovarian reserve tests in infertility practice and normal fertile women. Maturitas 1998;30:205-214.
40. van Rooij IA, Tonkelaar I, Broekmans FJ, et al. Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 2004; 11 (6 Pt 1):601-606.
41. Erdem A, Erdem M, Biberoglu K, et al. Age-related changes in ovarian volume, antral follicle counts and basal FSH in women with normal reproductive health. J Reprod Med 2002;47:835-839.
42. Santoro N, Lasley B, McConnell D, et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: the Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab 2004;89:2622-2631.
43. Welt CK, McNicholl DJ, Taylor AE, et al. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999;84:105-111.
44. van Disseldorp J, Faddy MJ, Themmen AP, et al. Relationship of serum antimullerian hormone concentration to age at menopause. J Clin Endocrinol Metab 2008;93:2129-2134.
45. de Vet A, Laven JS, de Jong FH, et al. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-362. (Pubitemid 34083560)
46. 46. Freeman EW, Gracia CR, Sammel MD, et al. Association of anti-mullerian hormone levels with obesity in late reproductiveage women. Fertil Steril 2007;87:101-106. (Pubitemid 46013875)
47. van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005;83:979-987.
48. Sowers MR, Eyvazzadeh AD, McConnell D, et al. Antimullerian hormone and Inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478-3483.
49. Freeman EW, Sammel MD, Gracia CR, et al. Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril 2005;83:383-392.
50. LentonEA,SextonL,LeeS,etal.ProgressivechangesinLHandFSHandLH: FSHratioinwomenthroughoutreproductivelife.Maturitas1988;10:35-43. (Pubitemid18149609)
51. Santoro N, Brockwell S, Johnston J, et al. Helping midlife women predict the onset of the final menses: SWAN, the study of women's health across the nation. Menopause 2007;14(3 R 1):415-424.
52. McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med 1985;103:350-356.
53. 53. Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001;153:865-874. (Pubitemid 32378620)
54. Scott RT, Toner JP, Muasher SJ, et al. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-654.
55. Cramer DW, Barbieri RL, Fraer AR, et al. Determinants of early follicular phase gonadotrophin and estradiol concentrations in women of late reproductive age. Hum Reprod 2002;17:221-227.
56. Cooper GS, Baird DD, Hulka BS, et al. Follicle-stimulating hormone concentrations in relation to active and passive smoking. Obstet Gynecol 1995;85:407-411.
57. MacMahon B, Worcester J. Age at menopause. United States-1960-1962. Vital Health Stat 11 1966:1-20.
58. Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995;80: 3537-3545.
59. Steiner AZ, Baird DD, Kesner JS. Mother's menopausal age is associated with her daughter's early follicular phase urinary follicle-stimulating hormone level. Menopause 2008;15: 940-944.
60. Lambert-Messerlian GM, Harlow BL. The influence of depression, body mass index, and smoking on serum inhibin B levels in late reproductive-aged women. J Clin Endocrinol Metab 2006;91:1496-1500.
61. FreourT,MassonD,MirallieS,etal. ActivesmokingcompromisesIVFoutcomeandaffectsovarianreserve. ReprodBiomedOnline2008;16:96-102.(Pubitemid351187378)
62. Gracia CR, Freeman EW, Sammel MD, et al. The relationship between obesity and race on inhibin B during the menopause transition. Menopause 2005;12:559-566.
63. Steiner AZ, Stanczyk FZ, Patel S, et al. The effects of hormonal contraceptives on antimullerian hormone by obesity status. Reprod Sci 2008;15(suppl 1):308A.
64. 64. Lawson R, El Toukhy T, Kassab A, et al. Poor response to ovulation induction is a stronger predictor of early meno- pause than elevated basal FSH: a life table analysis. Hum Reprod 2003;18:527-533. (Pubitemid 36329319)
65. Nikolaou D, Lavery S, Turner C, et al. Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod 2002;17:1106-1111.
66. de Boer EJ, den Tonkelaar I, te Velde ER, et al. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002;77:978-985.
67. Farhi J, Homburg R, Ferber A, et al. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure preempting the rise in basal follicle stimulating hormone levels. Hum Reprod 1997;12:241-243. (Pubitemid 27129379)
68. FiciciogluC,KutluT,DemirbasogluS,etal. TheroleofinhibinBasabasaldeterminantofovarianreserve.GynecolEndocrinol2003;17: 287-293.(Pubitemid37083034)
69. Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 1999;14:409-415.
70. Eldar-Geva T, Margalioth EJ, Ben Chetrit A, et al. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod 2002; 17:2331-2337.
71. Seifer DB, Scott RT Jr, Bergh PA, et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril 1999;72:63-65.
72. van Rooij IA, Broekmans FJ, te Velde ER, et al. Serum anti-mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-3071.
73. Tremellen KP, Kolo M, Gilmore A, et al. Anti-mullerian hormone as a marker of ovarian reserve. Aust NZJ Obstet Gynaecol 2005;45:20-24.
74. 74. Silberstein T, MacLaughlin DT, Shai I, et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod 2006;21:159-163. (Pubitemid 41794305)
75. MuasherSJ,OehningerS,SimonettiS,etal.Thevalueofbasaland/ orstimulatedserumgonadotropinlevelsinpredictionofstimulationresponseandinvitrof ertilizationoutcome.FertilSteril1988;50:298-307.(Pubitemid18195646)
76. SharifK,ElgendyM,LashenH,etal. Ageandbasalfolliclestimulatinghormoneaspredictorsofinvitrofertilizationoutcome. BrJObstetGynaecol1998;105:107-112.(Pubitemid28025366)
77. 77. Jain T, Soules MR, Collins JA. Comparison of basal folliclestimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening. Fertil Steril 2004;82:180-185. (Pubitemid 38968796)
78. Bancsi LF, Broekmans FJ, Mol BW, et al. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 2003;79:1091-1100.
79. Oosterhuis GJ, Vermes I, Michgelsen HW, et al. Follicle stimulating hormone measured in unextracted urine throughout the menstrual cycle correlates with age and ovarian reserve. Hum Reprod 2002;17:641-646.
80. 80. Liu JH, Kao L, Rebar RW, et al. Urinary beta-FSH subunit concentrations in perimenopausal and postmenopausal women: a biomarker for ovarian reserve. Menopause 2003; 10:526-533. (Pubitemid 40228147)
81. Santoro N, Brown JR, Adel T, et al. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996;81:1495-1501.
82. Oosterhuis GJ, Lambalk CB, Michgelsen HW, et al. Folliclestimulating hormone measured in unextracted urine: a reliable tool for easy assessment of ovarian capacity. Fertil Steril 1998;70:544-548.
83. 83. Erdem M, Erdem A, Gursoy R, et al. Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF. J Assist Reprod Genet 2004;21:37-45. (Pubitemid 39028875)
84. Kwee J, Elting MW, Schats R, et al. Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study. Hum Reprod 2003;18:1422-1427.
85. Bancsi LF, Broekmans FJ, Eijkemans MJ, et al. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-336.
86. Yong PY, Baird DT, Thong KJ, et al. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod 2003;18:35-44.
87. CreusM,PenarrubiaJ,FabreguesF,etal. Day3seruminhibinBandFSHandageaspredictorsofassistedreproductiontreatmentoutcome. HumReprod2000;15:2341-2346.(Pubitemid30827188)
88. 88. Johnson NP, Bagrie EM, Coomarasamy A, et al. Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology: the International Systematic Collaboration of Ovarian Reserve Evaluation protocol for a systematic review of ovarian reserve test accuracy. BJOG 2006; 113:1472-1480. (Pubitemid 44736695)
89. Aging and infertility in women. Fertil Steril 2006;86 (suppl 5):S248-S252.
90. van der Steeg JW, Steures P, Eijkemans MJ, et al. Predictive value and clinical impact of Basal follicle-stimulating hormone in subfertile, ovulatory women. J Clin Endocrinol Metab 2007;92:2163-2168. (Pubitemid 46997116)
91. WeghoferA, Margreiter M, Fauster Y, et al. Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction. Hum Reprod 2005;20:2448-2452.
92. Toner JP, Philput CB, Jones GS, et al. Basal folliclestimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-791.
93. Chuang CC, Chen CD, Chao KH, et al. Age is a better predictor of pregnancy potential than basal folliclestimulating hormone levels in women undergoing in vitro fertilization. Fertil Steril 2003;79:63-68.
94. Toner JP. Modest follicle-stimulating hormone elevations in younger women: warn but don't disqualify. Fertil Steril 2004; 81:1493-1495.
95. Wolff EF, Taylor HS. Value of the day 3 follicle-stimulating hormone measurement. Fertil Steril 2004;81:1486-1488.
96. 96. Abdalla H, Thum MY. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 2004;19:893-898. (Pubitemid 38456055)
97. Scott RT, Opsahl MS, Leonardi MR, et al. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 1995;10: 1706-1710.
98. El Toukhy T, Khalaf Y, Hart R, et al. Young age does not protect against the adverse effects of reduced ovarian reserve-an eight year study. Hum Reprod 2002;17:1519-1524.
99. Kumbak B, Oral E, Kahraman S, et al. Young patients with diminished ovarian reserve undergoing assisted reproductive treatments: a preliminary report. Reprod Biomed Online 2005;11:294-299.
100. RichardsonSJ,SenikasV,NelsonJF. Folliculardepletionduringthemenopausaltransition: evidenceforacceleratedlossandultimateexhaustion.JClinEndocrinolMetab1987;65: 1231-1237.(Pubitemid18026863)
101. den Tonkelaar I, te Velde ER, Looman CW. Menstrual cycle length preceding menopause in relation to age at menopause. Maturitas 1998;29:115-123.
102. Kwee J, Schats R, McDonnell J, et al. Intercycle variability of ovarian reserve tests: results of a prospective randomized study. Hum Reprod 2004;19:590-595.
103. Penarrubia J, Fabregues F, Manau D, et al. Initial analysis of variability among basal hormone biomarkers of ovarian reserve. Reprod Biomed Online 2004;8:191-195.
104. Jain T, Klein NA, Lee DM, et al. Endocrine assessment of relative reproductive age in normal eumenorrheic younger and older women across multiple cycles. Am J Obstet Gynecol 2003;189:1080-1084.
105. 105. Abdalla H, Thum MY. Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH. Hum Reprod 2006;21:171-174. (Pubitemid 41794307)
106. Scott RT Jr, Hofmann GE, Oehninger S, et al. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54:297-302.
107. 107. Soares SR, Troncoso C, Bosch E, et al. Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. J Clin Endocrinol Metab 2005;90:4399-4404. (Pubitemid 41058227)
108. Levi AJ, Raynault MF, Bergh PA, et al. Reproductive outcome in patients with diminished ovarian reserve. Fe;rtil Steril 2001 ;76:666-669.
109. Gurbuz B, Yalti S, Ozden S, et al. High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss. Arch Gynecol Obstet 2004;270:37-39.
110. Nasseri A, Mukherjee T, Grifo JA, et al. Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy. Fertil Steril 1999;71:715-718.
111. van Montfrans JM, Lambalk CB, van Hooff MH, et al. Are elevated FSH concentrations in the pre-conceptional period a risk factor for Down's syndrome pregnancies? Hum Reprod 2001;16:1270-1273.
112. van Montfrans JM, van Hooff MH, Huirne JA, et al. Basal FSH concentrations as a marker of ovarian ageing are not related to pregnancy outcome in a general population of women over 30 years. Hum Reprod 2004;19:430-434.
113. Joffe M, Li Z. Association of time to pregnancy and the outcome of pregnancy. Fertil Steril 1994;62:71-75.
114. Schaumburg I, Boldsen JL. Waiting time to pregnancy and pregnancy outcome among Danish workers in the textile, clothing, and footwear industries. Scand J Soc Med 1992; 20:110-114.
115. Hofmann GE, Khoury J, Thie J. Recurrent pregnancy loss and diminished ovarian reserve. Fertil Steril 2000;74:1192-1195.